Green Cross to launch "Laennec" an injectable placenta.

Published: 2005-06-17 07:00:00

Updated: 2005-06-17 07:00:00

Green Cross has launched Laennec injectable placenta preparation in the market under a certain distribution arrangement with GCJBP who is producing Laennec under a joint venture between Green Cross and Japanese Biological Co., a leading manufacturer of placenta related products.

Green Cross sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK